Panacea Biotec

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE922B01023
  • NSEID: PANACEABIO
  • BSEID: 531349
INR
322.90
-1.75 (-0.54%)
BSENSE

Apr 02

BSE+NSE Vol: 62.63 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 622974,
    "name": "Panacea Biotec",
    "stock_name": "Panacea Biotec",
    "full_name": "Panacea Biotec Ltd",
    "name_url": "stocks-analysis/panacea-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "322.90",
    "chg": -1.75,
    "chgp": "-0.54%",
    "dir": -1,
    "prev_price": "324.65",
    "mcapval": "1,953.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 531349,
    "symbol": "PANACEABIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE922B01023",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "62.63 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/panacea-biotec-622974-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "622974",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/panacea-biotec-622974"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Cessation",
      "datetime": "01-Apr-2026",
      "details": "We would like to inform you that Mr. Mukul Gupta (DIN: 00254597) Independent Director of the Company has completed his second and final term of 5 consecutive years as Independent Director on 31.03.2026 and accordingly he has ceased to be the Independent Director of the Company. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 3.01.2026 is enclosed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "01-Apr-2026",
      "details": "We would like to inform you that Mr. Mukul Gupta (DIN: 00254597) Independent Director of the Company has completed his second and final term of 5 consecutive years as Independent Director on 31.03.2026 and accordingly he has ceased to be an Independent Director of the Company. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 30.01.2026 is annexed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "31-Mar-2026",
      "details": "We would like to inform you that the Company has received a Demand Order dated 30.03.2026 from the Office of the Joint Commissioner CGST Sub- Commissionerate Mohali Chandigarh under CGST / IGST Act 2017 raising a demand of Rs.22.88 Crore towards non-payment of GST including penalty thereon. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 30.01.2026 and Industry Standards on Regulation 30 of SEBI LODR Regulations are enclosed herewith.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Panacea Biotec Ltd has declared <strong>75%</strong> dividend, ex-date: 19 Sep 11",
          "dt": "2011-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Cessation

01-Apr-2026 | Source : BSE

We would like to inform you that Mr. Mukul Gupta (DIN: 00254597) Independent Director of the Company has completed his second and final term of 5 consecutive years as Independent Director on 31.03.2026 and accordingly he has ceased to be the Independent Director of the Company. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 3.01.2026 is enclosed herewith.

Announcement under Regulation 30 (LODR)-Change in Directorate

01-Apr-2026 | Source : BSE

We would like to inform you that Mr. Mukul Gupta (DIN: 00254597) Independent Director of the Company has completed his second and final term of 5 consecutive years as Independent Director on 31.03.2026 and accordingly he has ceased to be an Independent Director of the Company. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 30.01.2026 is annexed herewith.

Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

31-Mar-2026 | Source : BSE

We would like to inform you that the Company has received a Demand Order dated 30.03.2026 from the Office of the Joint Commissioner CGST Sub- Commissionerate Mohali Chandigarh under CGST / IGST Act 2017 raising a demand of Rs.22.88 Crore towards non-payment of GST including penalty thereon. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 30.01.2026 and Industry Standards on Regulation 30 of SEBI LODR Regulations are enclosed herewith.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Panacea Biotec Ltd has declared 75% dividend, ex-date: 19 Sep 11

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available